发明名称 USE OF IL-1β BINDING ANTIBODIES
摘要 <p>The present invention relates to a method for treating or alleviating the symptoms of abdominal aortic aneurysm (AAA) in a subject, comprising administering about 25 mg to about 300 mg of an IL-1β binding antibody or functional fragment thereof, and wherein the subject has infrarenal abdominal aortic aneurysm with maximum diameter of ≥30 mm and ≤60 mm before treatment..</p>
申请公布号 WO2015083120(A1) 申请公布日期 2015.06.11
申请号 WO2014IB66601 申请日期 2014.12.04
申请人 NOVARTIS AG;DOLE, WILLIAM 发明人 DOLE, WILLIAM
分类号 C07K16/24;A61K39/00 主分类号 C07K16/24
代理机构 代理人
主权项
地址